Johnson & Johnson to acquire biotechnology company Firefly Bio for $1 billion in cash.
Related
Novartis acquires British biotechnology company Myricx Bio for $1.5 billion
Novartis has agreed to acquire Myricx Bio, a UK-based cancer treatment group, in a deal that could be worth up to $1.5 billion, marking the latest acquisition of a British biotechnology company by a foreign firm. (Sina Finance)
Abu Dhabi National Oil Company's distribution arm plans to acquire 100% of Shell's South African downstream business for $1 billion.
Mars Finance reported on July 7th that ADNOC Distribution, a subsidiary of Abu Dhabi National Oil Company, announced its plan to acquire 100% of Shell's South African downstream business for approximately US$1 billion. Following the transaction, a 28% stake will be sold to local empowerment partners and an employee stock ownership plan. The company expects the transaction to drive EBITDA growth of approximately 13% and earnings per share growth of approximately 6% in the first year after completion. The transaction is expected to close in 2027. (Wide Angle Observation)
US infrastructure company MasTec invests another $1.65 billion to strengthen its data center electrical footprint.
Mars Finance reports that US infrastructure engineering and construction company MasTec announced on Tuesday that it will acquire electrical contractor The Superior Group for approximately $1.65 billion to enhance its electrical service capabilities in the rapidly expanding data center infrastructure market. The transaction, conducted in cash and stock, is expected to close in mid-to-late July. (Cailian Press)
Estun: Planning to acquire a stake in Estun Kootron, a company specializing in embodied intelligent robots.
Mars Finance reported on July 2nd that Estun announced that its stock price had deviated by more than 20% cumulatively over three consecutive trading days, constituting abnormal stock trading fluctuations. After verification, the company's production and operations are normal, and there have been no significant changes in the internal or external environment. Currently, it is planning to acquire a stake in Nanjing Estun Kootech Technology Co., Ltd. through its wholly-owned subsidiary via cash. Upon completion of the transaction, it will indirectly hold 100% of the company's equity. Estun Kootech's main business is the R&D, production, and sales of collaborative robots, embodied intelligent robots, and their core components. Its main products are collaborative robots and embodied intelligent robots with a payload of 3-35kg and their core components. Downstream applications mainly include the automotive, home appliance, 3C electronics, and food logistics industries. Advanced Manufacturing Industry Investment Fund Phase II (Limited Partnership) holds 23.2558% of the target company's equity. (Company Announcement)
Chip startup SambaNova raises $1 billion, valuing the company at $11 billion.
Mars Finance reported on July 8th that SambaNova Systems, a chip startup backed by Intel's venture capital arm, has completed a $1 billion Series F funding round, valuing the company at $11 billion. The company is scheduled to officially announce the news on July 8th local time. (Wide Angle Observation)
Shenzhen-based smart glasses company Ewen Technology has completed a $150 million funding round, valuing the company at over $1 billion post-investment.
Mars Finance reported on July 7th that Shenzhen-based smart glasses company Even Realities announced the completion of a $150 million Pre-B round of financing, valuing the company at over $1 billion post-money and officially joining the ranks of unicorns. This round was led by Meituan Dragon Ball and Meituan Strategic Investment, with existing shareholders Yuan Yi Capital and Tencent oversubscribing. Earlier this year, Even Realities also completed an A++ round of financing, co-led by Guanghe Venture Capital and Yuan Yi Capital, with existing shareholders including Dachen Capital oversubscribing. (Venture Capitalist CLUB)